AstraZeneca posts $2.18bn profit after tax in Q1 2024
AstraZeneca has reported profit after tax of $2.18bn for the first quarter (Q1) of 2024, a notable rise from $1.80bn reported in the same period last year. This growth has been attributed to robust sales in the company’s cancer drug portfolio. The company’ …